Iodoquinol Hydrocortisone Acetate Aloe Polysaccharides
NDC Package 72056-020-48

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Iodoquinol Hydrocortisone Acetate Aloe Polysaccharides is based on a review of a related drug by the National Research Council and subsequent FDA classification for that drug, the indications are as follows: "Possibly" Effective: Contact or atopic dermatitis; impetiginized eczema; nummular eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; localized or disseminated neurodermatitis; lichen simplex chronicus; anogenital pruritus (vulvae, scroti, ani); folliculitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); monliasis; intertrigo. Marketed by Syntenza Pharmaceuticals Llc, this product is identified by NDC 72056-020.

Identification & Billing

NDC Package Code
72056-020-48
Package Description
1 TUBE in 1 CARTON / 48 g in 1 TUBE
Product Code
72056-020
11-Digit Billing Format
72056002048
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
48 GM
RxNorm Crosswalk
  • RxCUI: 1191376 - iodoquinol 1 % / hydrocortisone acetate 2 % / aloe polysaccharides 1 % Topical Gel
  • RxCUI: 1191376 - aloe polysaccharide 0.01 MG/MG / hydrocortisone acetate 0.02 MG/MG / iodoquinol 0.01 MG/MG Topical Gel
  • RxCUI: 1191376 - aloe polysaccharides 1 % / hydrocortisone acetate 2 % / iodoquinol 1 % Topical Gel

Clinical Specifications

Proprietary Name
Iodoquinol Hydrocortisone Acetate Aloe Polysaccharides
Dosage Form
-
Usage Information
Based on a review of a related drug by the National Research Council and subsequent FDA classification for that drug, the indications are as follows: "Possibly" Effective: Contact or atopic dermatitis; impetiginized eczema; nummular eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; localized or disseminated neurodermatitis; lichen simplex chronicus; anogenital pruritus (vulvae, scroti, ani); folliculitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); monliasis; intertrigo. Final classification of the less-than-effective indications requires further investigation.

Regulatory & Marketing

Labeler Name
Syntenza Pharmaceuticals Llc
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
11-01-2018
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72056-020-48 identifies a specific commercial package of 1 tube in 1 carton / 48 g in 1 tube of Iodoquinol Hydrocortisone Acetate Aloe Polysaccharides, labeled by Syntenza Pharmaceuticals Llc. This product is billed per "GM" gram and contains an estimated amount of 48 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Syntenza Pharmaceuticals Llc on November 01, 2018. The current certification is valid through December 31, 2021.

How is this Syntenza Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72056002048. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 48 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72056-020-48
11-Digit CMS (5-4-2)
72056-0020-48

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.